Organisational Committee

Professor Ernst Wolvetang

Co-Director, UQ Centre in Stem Cell Ageing and Regenerative Engineering; Professor Stem Cell Engineering Laboratory, Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Australia.

Ernst obtained his PhD from the University of Amsterdam, and continued his post-doctoral training at the Monash Institute for Reproduction and Development. In 2008 he was recruited to the AIBN. He is a leader in the derivation, genome editing and disease modelling with human induced pluripotent stem cells, is the inaugural director of “Cell Reprogramming Australia”, and a principal investigator in the ARC Centre of Excellence “Stem Cells Australia”. He was awarded the 2014 LSQ regenerative medicine prize. Professor Wolvetang serves on the editorial board of six stem cell journals; is listed inventor on four patents in stem cell research and he serves as a scientific advisor to the Massimo Foundation.


Professor Justin Cooper-White

Co-Director, UQ Centre in Stem Cell Ageing and Regenerative Engineering; Professor  Tissue Engineering and Microfluidics Laboratory, Australian Institute for Bioengineering and Nanotechnology, University of Queensland; CSIRO Office of the Chief Executive Science Leader CSIRO Manufacturing, Biomedical Manufacturing Program; Director, Australian National Fabrication Facility – Queensland Node; Editor-in-Chief, APL Bioengineering AIP Publishing, New York; Adjunct Professor, Australian Regenerative Medicine Institute, Monash University.

Justin obtained his PhD from the University of Queensland, and continued his postdoctoral training at the University of Melbourne in the Department of Chemical and Biomolecular Engineering, in which he was appointed Senior Lecturer in 2003. He was recruited back to UQ to lead an initiative in Tissue Engineering in 2004 in the School of Chemical Engineering and in 2007, was one of the inaugural Group Leaders recruited to the AIBN. He is a global leader in using engineering to solve problems in biology. His team specialises in elucidating the microenvironmental cues that regulate stem cell behaviours and translating those insights into novel delivery systems, biomaterial scaffolds and microdevices to direct stem cell differentiation and tissue repair. Most recently, he has focused his attention to understanding stem cell and niche ageing, and the development of innovative engineered solutions to achieve system-wide rejuvenation.

He is a past President of both the Australasian Society for Biomaterials and Tissue Engineering and the Australian Society of Rheology and has received numerous awards, including most recently the NHMRC Marshall and Warren Award for Research Excellence (awarded 2016) and the AON Insurance Regenerative Medicine Award (2015). He is an inventor on 6 granted International Patents in the fields of Stem Cells, Biomaterials and Biomicrodevice technology, and co-founder and Chief Scientific Officer of a new start-up company based in the USA, Scaled Biolabs Inc., that leverages microfluidics, automation and machine learning to power cell-based medicines.


Associate Professor Victoria Cogger

Associate Professor, Concord Clinical School of Sydney Medical School, University of Sydney Australia, Ageing and Alzheimers Institute and ANZAC Research Institute, President of the International Society of Hepatic Sinusoidal Research (since 2017).Victoria completed an Australian Government Healthy Ageing Postdoctoral Fellowship at the National Institutes of Health, Bethesda MD USA (2005-2006) on confocal and live cell imaging in the laboratories of Professor Irwin Arias and Dr. Jennifer Lippincott-Schwarz.Since her return to Australia Victoria has been in the Biogerontology laboratory at the ANZAC Research Institute investigating the biology of the liver in health, ageing and disease; with particular focus on the endothelial cell and their fenestrae. Her research characterises ageing changes in the blood vessels of organs like the liver and brain. Victoria’s goal is to understand these and other ageing changes so we can better guide lifestyle and develop interventions to prevent age-related disease and disability.


Professor David Le Couteur AO

Professor of Geriatric Medicine at the University of Sydney, Director of the Centre for Education and Research on Ageing (CERA), Director of the Biogerontology Laboratory of the ANZAC Medical Research Institute and Senior Staff Specialist Physician in Geriatric Medicine at the Concord Repatriation General Hospital in Sydney.

His research is translational gerontology, spanning from biogerontology (nutrition, liver pharmacology and physiology); clinical research (geriatric pharmacology and the application of evidence based medicine to older people) and epidemiology (chief investigator and pharmacoepidemiologist on the Concord Health and Ageing Male Project CHAMP, a multidisciplinary prospective epidemiological study of 1705 older men now in its eighth year).


Dr Matt Piper

ARC Future Fellow, Head Piper Research Lab, Monash University, Melbourne, Australia.

Matt received his PhD in Biochemistry and Molecular Genetics in 2001 from UNSW. He then did his postdoc at the Technical University of Delft, NL and later University College London, UK. He returned to Australia in 2016 to take up an independent group leader position at Monash University.

He is interested in how nutrition affects various aspects of fitness and and long-term health. His model organism of choice is the fruit fly Drosophila melanogaster. Dietary restriction (DR or calorie restriction) is an evolutionarily conserved intervention that extends healthy lifespan. His team is interested in the nutrients and molecular mechanisms required to elicit this effect – in particular the role of protein. Knowledge of these interactions will aid our understanding of the role of nutrient balance in adult health, appetite and longevity.


Dr Lindsay Wu


Lindsay Wu has run the Laboratory for Ageing Research at UNSW Australia with Professor David Sinclair since 2011, after completing his PhD in the diabetes and obesity program at the Garvan Institute. A major theme of the lab is the role of NAD+ metabolism in ageing, and its role in cellular senescence, fertility, muscle function, mitochondrial function diabetes and cancer, as well as accelerated ageing caused by chemotherapy. The lab is also interested in understanding how epigenetic dysregulation occurs during ageing, and how this is influenced by metabolism.

Associate Professor Genevieve Healey

Genevieve is a NHMRC Career Development Fellow at the School of Public Health at the University of Queensland. Her research focuses on understanding how much we sit and how this influences our health and wellbeing, as well as the feasibility and acceptability of reducing this behaviour in key settings and populations, including older adults. Her work has influenced policy and guidelines regarding the importance of reducing prolonged sitting time, and she works with multiple industry and partner organisations to translate her research into practice.


Dr Paul Gardiner

Paul Gardiner completed a PhD in Public Health at the University of Queensland and is currently a NHMRC-ARC Dementia Research Development Fellow in The University of Queensland’s Centre for Health Services Research. He is an epidemiologist and behaviour change scientist with experience in biomedical, clinical, and public health research and his research is focused on understanding how prolonged sitting time may impact on age-related declines in cognitive, physical and lung function. He is a member of the Our Voice Citizen Science Global Network, which is focused on advancing health equity; President of the Queensland Branch of the Public Health Association of Australia; and, founder and co-Chair of the Ageing Special Interest Group of the International Society of Behavioral Nutrition and Physical Activity.



Held on the 25-26 June at the University of Queensland, the conference will bring together researchers to discuss highly innovative and multidisciplinary research programs to tackle the challenges of the demographic change of an ageing society with a particular focus on Stem Cells, Ageing & Rejuvenation.